Global /Canada /Healthcare /Drug Manufacturers - General /GSD

Devonian Health Group Inc.

GSD

• TSXV: GSD • Delayed

11.90CAD 0%

8.56 USD

As of 5 June 2026, Devonian Health Group Inc. has a market cap of $23.81M USD, ranking #35883 globally and #1245 in Canada. It ranks #3224 in the Healthcare sector, and #1087 in the Drug Manufacturers - General industry.

Global Rank

35883

Country Rank

1245

Sector Rank

3224

Industry Rank

1087

Key Stats

Market Cap

$23.81MUSD

33.09M CAD

Enterprise Value

$22.99MUSD

31.96M CAD

Revenue (TTM)

$7.33MUSD

10.18M CAD

EBITDA (TTM)

-$2.94MUSD

-4.08M CAD

Net Income (TTM)

-$6.46MUSD

-8.98M CAD

EBITDA Margin

-40%

Profit Margin

-88%

PS Ratio

3.3

PB Ratio

4.2

Company Profile

Country (HQ)

Canada

Sector

Healthcare

Industry

Drug Manufacturers - General

CEO

Andre Boulet open_in_new

Employees

Website

groupedevonian.com open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
0%	19%	-4%	4.4%	17%	4.4%	10%	4.4%	-29%

Upcoming Earnings

Earnings Date

Thu, Jun 25

News

Markets

Exchange	Ticker	Price	Quotes
TSX Venture Exchange (TSXV) MIC: XTSX PRIMARY	GSD ISIN: CA2518348834 Shares Out.: Shares Outstanding: 2.781M¹ Shares Float: 2.444M² TV: TradingView: TSXV: GSD SA: Stock Analysis: TSXV: GSD YF: Yahoo Finance: GSD.V GF: Google Finance: CVE: GSD BA: Barron's: GSD MS: Morningstar: XTSX: GSD	11.90 CAD	TV: TradingView: TSXV: GSD SA: Stock Analysis: TSXV: GSD YF: Yahoo Finance: GSD.V GF: Google Finance: CVE: GSD BA: Barron's: GSD MS: Morningstar: XTSX: GSD
Cboe Canada (NEO) MIC: NEOE	GSD Devonian Health Group Inc Ordinary Shares - New ISIN: CA2518348008 Shares Out.: Shares Outstanding: 165.944M¹ Shares Float: 144.709M² TV: TradingView: NEO: GSD SA: Stock Analysis: NEO: GSD YF: Yahoo Finance: GSD.NE GF: Google Finance: NEO: GSD BA: Barron's: GSD MS: Morningstar: NEOE: GSD	0.1800 CAD	TV: TradingView: NEO: GSD SA: Stock Analysis: NEO: GSD YF: Yahoo Finance: GSD.NE GF: Google Finance: NEO: GSD BA: Barron's: GSD MS: Morningstar: NEOE: GSD
OTC Markets (OTCMKTS / OTC) MIC: OTCM	DVHGF Devonian Health Group Inc Ordinary Shares - New ISIN: CA2518348008 Shares Out.: Shares Outstanding: 148.223M¹ Shares Float: 126.988M² TV: TradingView: OTC: DVHGF SA: Stock Analysis: OTC: DVHGF YF: Yahoo Finance: DVHGF GF: Google Finance: OTCMKTS: DVHGF BA: Barron's: DVHGF MS: Morningstar: PINX: DVHGF	0.1800 USD	TV: TradingView: OTC: DVHGF SA: Stock Analysis: OTC: DVHGF YF: Yahoo Finance: DVHGF GF: Google Finance: OTCMKTS: DVHGF BA: Barron's: DVHGF MS: Morningstar: PINX: DVHGF

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About Devonian Health Group Inc.

Devonian Health Group Inc. engages in the development of botanical drugs. Its lead product candidate is Thykamine that is in phase 3 clinical trial for the treatment of Atopic dermatitis in adult population; in phase 2/3 clinical trial for Atopic dermatitis in pediatric population; in phase 2 clinical trial for HFS associated to chemotherapy; and in phase 2/3 clinical trial for Radiodermatitis associated to radiotherapy, as well as in phase 2a clinical trial for ulcerative colitis. The company also develops Pantoprazole Magnesium for the treatment of gastric reflux; Cleo-35 for the treatment of hormonal acne in women; R-Spinasome anti-aging cream, serum, and regenerating creams; and anti-aging products, including day, night, and eye creams under the Purgenesis name. Devonian Health Group Inc. is headquartered in Québec, Canada.

Similar Companies

Industry: Drug Manufacturers - General (Canada)

Name	Market Cap (USD) diff.	PE	Country
Xenon Pharmaceuticals Inc. NASDAQ: XENE	$5.39B 23K%	-	Canada
Knight Therapeutics Inc. TSX: GUD	$521.69M 725.1M CAD 2K%	-	Canada
Milestone Pharmaceuticals Inc. NASDAQ: MIST	$223.22M 838%	-	Canada
Satellos Bioscience Inc. TSX: MSCL	$156.02M 216.85M CAD 555%	-	Canada
BioSyent Inc. TSXV: RX	$119.33M 165.86M CAD 401%	18.5	Canada
Helix BioPharma Corp. TSX: HBP	$111.0M 154.28M CAD 366%	-	Canada

Industry: Drug Manufacturers - General (Global)

Name	Market Cap (USD) diff.	PE	Country
Eli Lilly and Co. NYSE: LLY	$761.68B 3M%	38.1	United States
Johnson & Johnson NYSE: JNJ	$547.28B 2M%	26.4	United States
AbbVie Inc. NYSE: ABBV	$360.63B 2M%	97.4	United States
Roche Holding AG SIX: RO	$323.4B 256.25B CHF 1M%	19.9	Switzerland
AstraZeneca PLC LSE: AZN	$289.25B 215.59B GBP 1M%	27.6	United Kingdom
Novartis AG SIX: NOVN	$276.26B 218.9B CHF 1M%	20.5	Switzerland

chevron_leftBack